Exhibit 99.1 National Vision Holdings, Inc. Reports Third Quarter 2024 Financial Results Results Reflect Ongoing Strength in Managed Care with Growth in America's Best as Transformation Initiatives Progress Third quarter 2024 highlights compared to Q3 2023: • Net revenue from continuing operations of $451.5 million, an increase of 2.9% • Comparable store sales growth of 1.4% and Adjusted Comparable Store Sales Growth of 0.9% • Net loss from continuing operations of $(8.4) million, Diluted EPS from continuin ...

Wall Street expects a year-over-year decline in earnings on lower revenues when National Vision (EYE) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on November 6, 2024, might help the stock move higher if these key numbers are better th ...

National Vision, Inc. (EYE) has strengthened its existing partnership with Pair Eyewear, the first direct-toconsumer and leading customizable eyewear brand, by expanding to all 1,000+ America's Best stores. In addition to forming an exclusive retail partnership, the strategic collaboration establishes the company's Doctor of Optometry network as the popular online brand's official eye care provider. By purchasing an affordable bundle offer that includes one base frame and two top frames, customers can also ...

THOUSAND OAKS, Calif., Sept. 24, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high clinical activity score (CAS) Thyroid Eye Disease (TED) by Japan's Ministry of Health, Labour and Welfare (MHLW). PRODUCT NAME TEPEZZA® for Intravenous Infusion 500 mg Generic Name (JAN) Teprotumumab (Genetical Recombination) Indication Active thyroid eye disease Hearing disorders (e.g., deafness, hypoacusis, Eu ...

Leading Customizable Eyewear Brand Creates "Store Within a Store" at America's Best, Names National Vision Doctor of Optometry Network the Brand's Official Eye Care Provider DULUTH, Ga., Sept. 24, 2024 /PRNewswire/ -- National Vision, Inc., one of the nation's largest optical retailers providing quality, affordable eye care and eyewear, announced today it is solidifying its partnership with Pair Eyewear, the first direct-to-consumer and now leading customizable eyewear brand, by expanding to all 1,000+ Amer ...

National Vision Holdings, Inc.'s (EYE) growth is backed by the consistent market expansion of the Owned and Host segment. The company's strategic progress in terms of expanding exam capacity, recruitment and retention efforts and remote exam initiatives is highly encouraging. However, weak solvency and an ailing capital structure are concerning. Mounting expenses due to slow economic conditions also add to the worry. In the past year, this Zacks Rank #3 (Hold) company's shares have lost 33.4% against the in ...

In an exclusive retail partnership with National Vision's America's Best brand, the launch expands awardwinning actor Millie Bobby Brown's beloved beauty, lifestyle and fashion line to the American eyewear market. The collection, developed with eyewear manufacturer Mondottica Group, features a full range of sun and optical eyewear styles designed to curate confidence in the next generation. The inclusive and intentional eyewear styles were crafted to make the wearer feel joyful and empowered through the bra ...

National Vision Holdings, Inc. (EYE) delivered an adjusted EPS (earnings per share) of 15 cents in the second quarter of 2024 compared with 17 cents in the year-ago period. The figure surpassed the Zacks Consensus Estimate of 6 cents. The GAAP loss from continuing operations was 1 cent per share compared to an EPS of 5 cents in the prioryear quarter. Revenues in Detail On Feb 23, 2024, National Vision completed the termination of the Walmart Management and Services Agreement and discontinued the former Lega ...

National Vision Holdings Inc (NASDAQ:EYE) Q2 2024 Results Conference Call August 6, 2024 4:30 PM ET Company Participants Tamara Gonzalez - IR Reade Fahs - CEO, President & Director Melissa Rasmussen - Senior VP & CFO Conference Call Participants Michael Lasser - UBS Simeon Siegel - BMO Capital Markets Anthony Chukumba - Loop Capital Markets Kate McShane - Goldman Sachs Zach Fadem - Wells Fargo Simeon Gutman - Morgan Stanley Brian Tanquilut - Jefferies Brandon Cheatham - Citigroup Adrienne Yih - Barclays Dyl ...

National Vision (EYE) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 150%. A quarter ago, it was expected that this discount optical retailer and eye care provider would post earnings of $0.28 per share when it actually produced earnings of $0.30, delivering a surprise of 7.14%. Ove ...